Koneksa Appoints Dr. Jessie Bakker as Vice President of Clinical Development
Koneksa , the evidence-based digital biomarkers company, today announced the appointment of Jessie Bakker, M.S., Ph.D., as Vice President (VP) of Clinical Development.
- Koneksa , the evidence-based digital biomarkers company, today announced the appointment of Jessie Bakker, M.S., Ph.D., as Vice President (VP) of Clinical Development.
- She brings a wealth of experience that will play a pivotal role in shaping Koneksa’s clinical program strategy from development through life-cycle management.
- Dr. Bakker has extensive experience in the development, validation, and deployment of digital tools in clinical trials within academia as well as with several device manufacturers.
- Dr. Bakker also has technology industry experience and held positions at Signifier Medical Technologies as the Executive Vice President of Medical Affairs, and at Philips Sleep and Respiratory Care as the Associate Director of Clinical Affairs.